P0C6X6 (R1AB_CVHOC) Human coronavirus OC43 (HCoV-OC43)

Replicase polyprotein 1ab UniProtKBInterProInteractive Modelling

7095 aa; Sequence (Fasta)

Molecule Processing
Host translation inhibitor nsp1
Non-structural protein 2
Papain-like proteinase
Non-structural protein 4
3C-like proteinase
Non-structural protein 6
Non-structural protein 7
Non-structural protein 8
Non-structural protein 9
Non-structural protein 10
RNA-directed RNA polymerase
Helicase
Guanine-N7 methyltransferase
Uridylate-specific endoribonuclease
2'-O-methyltransferase

Sequence Features

Add
 1074For PL1-PRO activity
 1225For PL1-PRO activity
 1671For PL2-PRO activity
 1828For PL2-PRO activity
 3287For 3CL-PRO activity
 3391For 3CL-PRO activity
 5124
 5125
 5126
 5989
 5991
 6090
 6167
 6172
 6842
 6926
 6966
 6999
 4306Zinc 1
 4309Zinc 1
 4315Zinc 1
 4322Zinc 1
 4348Zinc 2
 4351Zinc 2
 4359Zinc 2
 4361Zinc 2
 5302Zinc 3
 5305Zinc 3
 5313Zinc 4
 5316Zinc 3
 5323Zinc 3
 5326Zinc 4
 5330Zinc 4
 5336Zinc 4
 5347Zinc 5
 5352Zinc 5
 5369Zinc 5
 5372Zinc 5
 6106Zinc 6
 6109Zinc 6
 6125Zinc 6
 6128Zinc 6
 6156Zinc 7
 6160Zinc 7
 6163Zinc 7
 6178Zinc 7
 6346Zinc 8
 6367Zinc 8
 6378Zinc 8
 6381Zinc 8
 88H -> D (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 207C -> R (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 291P -> L (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 317C -> R (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 356F -> V (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 545I -> L (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 762D -> N (in strain: Isolate 87309 Belgium 2003)
 953F -> L (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003)
 989I -> V (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003)
 1305V -> A (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003)
 1328N -> D (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 1379F -> L (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 1504L -> V (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 1740G -> E (in strain: Isolate 87309 Belgium 2003)
 1825N -> K (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 1936S -> A (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003)
 1965N -> T (in strain: ATCC VR-759, Isolate clinical OC43-Paris)
 2004L -> S (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003)
 2022S -> G (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 2256I -> M (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 2257Q -> H (in strain: Isolate 87309 Belgium 2003)
 2386K -> R (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 2500I -> T (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003)
 2921D -> E (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 2961V -> I (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 3086T -> I (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 3440P -> L (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 3451L -> V (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 3466I -> V (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 4067I -> V (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 4071I -> V (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003)
 4382A -> T (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 4994I -> L (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate Tulsa 1999 and Isolate 87309 Belgium 2003)
 5765L -> S (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003)
 5997L -> R (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 6236G -> A (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 6454T -> A (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 6546F -> L (in strain: ATCC VR-759, Isolate clinical OC43-Paris and Isolate 87309 Belgium 2003)
 6636D -> E (in strain: Isolate 87309 Belgium 2003)
 6665A -> T (in strain: Isolate 87309 Belgium 2003)
 6754T -> A (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 2138-2158Helical
 2199-2219Helical
 2221-2241Helical
 2313-2333Helical
 2343-2363Helical
 2365-2385Helical
 2752-2772Helical
 2824-2844Helical
 3009-3029Helical
 3031-3051Helical
 3063-3083Helical
 3090-3110Helical
 3115-3135Helical
 3558-3578Helical
 3588-3608Helical
 3615-3635Helical
 3657-3677Helical
 3684-3704Helical
 3711-3731Helical
 3755-3775Helical
 1151-1179C4-type 1
 1749-1785C4-type 2
 4306-4322
 4348-4361
 5578-5585ATP
 246-247Cleavage; by PL1-PRO
 851-852Cleavage; by PL1-PRO
 2750-2751Cleavage; by PL2-PRO
 3246-3247Cleavage; by 3CL-PRO
 3549-3550Cleavage; by 3CL-PRO
 3836-3837Cleavage; by 3CL-PRO
 3925-3926Cleavage; by 3CL-PRO
 4122-4123Cleavage; by 3CL-PRO
 4232-4233Cleavage; by 3CL-PRO
 4369-4370Cleavage; by 3CL-PRO
 5297-5298Cleavage; by 3CL-PRO
 5900-5901Cleavage; by 3CL-PRO
 6421-6422Cleavage; by 3CL-PRO
 6796-6797Cleavage; by 3CL-PRO
 2138-2140TSA -> ISV (in strain: ATCC VR-759 and Isolate clinical OC43-Paris)
 5014-5015SD -> RT (in strain: Isolate Tulsa 1999)
 1-353Betacoronavirus NSP1
IPR022570PF11963
 678-850Non-structural protein 2, C-terminal domain, coronavirus
IPR043613PF19212
 1055-1285Peptidase C30/C16, Betacoronavirus
IPR002705PF01831
 1297-1401Macro domain
IPR002589PF01661
 1565-1866Peptidase C16, coronavirus
IPR013016PF08715
 1900-2016Non-structural protein NSP3, nucleic acid-binding (NAR) domain, betacoronavirus
IPR032592PF16251
 2250-2735Coronavirus replicase NSP3, C-terminal
IPR043611PF19218
 2772-3128Coronavirus replicase NSP4, N-terminal
IPR043612PF19217
 3153-3244Non-structural protein NSP4, C-terminal, coronavirus
IPR032505PF16348
 3275-3562Peptidase C30, coronavirus
IPR008740PF05409
 3577-3836Non-structural protein 6, coronavirus
IPR043610PF19213
 3837-3925Non-structural protein NSP7, coronavirus
IPR014828PF08716
 3926-4116Non-structural protein NSP8, coronavirus-like
IPR014829PF08717
 4123-4232Non-structural protein NSP9, coronavirus
IPR014822PF08710
 4241-4361RNA synthesis protein NSP10, coronavirus
IPR018995PF09401
 4383-4731RNA polymerase, N-terminal, coronaviral
IPR009469PF06478
 4764-5254RNA-directed RNA polymerase, C-terminal domain
IPR001205PF00680
 5729-5871DNA2/NAM7 helicase-like, C-terminal
IPR041679PF13087
 5902-6419Non-structural protein 14, coronavirus
IPR009466PF06471
 6422-6482Coronavirus replicase NSP15, N-terminal oligomerisation
IPR043606PF19219
 6492-6583Coronavirus replicase NSP15, middle domain
IPR043608PF19216
 6642-6794NendoU domain, nidovirus
IPR043609PF19215
 6799-7094Non-structural protein NSP16, coronavirus-like
IPR009461PF06460

Sequence Alignments

Papain-like proteinase 852-2750; PRO_0000283828

Oligo-stateLigandsQMEANTemplateRangeSeq id (%)
monomer ZN;-0.774ypt.1.A1487-1865
64.08
Assess

3C-like proteinase 3247-3549; PRO_0000283830

Oligo-stateLigandsQMEANTemplateRangeSeq id (%)
monomer 02J;-1.446jij.1.A3247-3545
83.06
Assess

RNA-directed RNA polymerase 4370-5297; PRO_0000037308

Oligo-stateLigandsQMEANTemplateRangeSeq id (%)
monomer ZN;-1.987c2k.1.A4370-5294
66.56
Assess

Uridylate-specific endoribonuclease 6422-6796; PRO_0000283838

Oligo-stateLigandsQMEANTemplateRangeSeq id (%)
monomer -2.362gti.1.A6422-6791
75.34
Assess